D.A. Davidson & Co’s ViewRay, Inc. VRAY Stock Holding History

D.A. Davidson & Co’s Portfolio VRAY Stock Details VRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,000	Closed	-$25K	–	2092
2017 Q2	$25K	Buy	+4,000	New	+$26.8K	﹤0.01%	1761

Other funds holding VRAY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

D.A. Davidson & Co's VRAY Position: Q3 2017 in Review

D.A. Davidson & Co sold out of ViewRay, Inc. (VRAY) in Q3 2017, closing a stake of 4,000 shares — an estimated $25K sold.

D.A. Davidson & Co first reported a position in VRAY in Q2 2017 and held it in 1 quarter. The position peaked at $25K in Q2 2017. 73 funds tracked by Wall St. Rank hold VRAY as of Q3 2017.

D.A. Davidson & Co reported no remaining ViewRay, Inc. position as of Q3 2017 after selling out during the quarter.
D.A. Davidson & Co sold 4,000 ViewRay, Inc. shares in Q3 2017, an estimated $25K.
D.A. Davidson & Co first reported a position in ViewRay, Inc. in Q2 2017 and held it in 1 quarter.
D.A. Davidson & Co's ViewRay, Inc. position peaked at $25K in Q2 2017.
73 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.